Unichem Laboratories Limited has received ANDA approval from US FDA for Unichem's Tramadol Hydrochloride Tablets USP, 50 mg. to market a generic version of Ultram® Tablets, 50 mg, of Janssen Pharmaceuticals, Inc. which are indicated in adults for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.
The Product will be commercialized from Unichem's Ghaziabad plant.
Shares of UNICHEM LABORATORIES LTD. was last trading in BSE at Rs.178 as compared to the previous close of Rs. 173.7. The total number of shares traded during the day was 4298 in over 94 trades.
The stock hit an intraday high of Rs. 179.55 and intraday low of 174.7. The net turnover during the day was Rs. 761299.